TY - JOUR
KW - Adolescent
KW - Adult
KW - African Continental Ancestry Group/statistics & numerical data
KW - Aged
KW - Antipsychotic Agents/therapeutic use
KW - Chronic Disease/epidemiology
KW - Comorbidity
KW - Cross-Sectional Studies
KW - Databases, Factual
KW - Diagnostic Tests, Routine/utilization
KW - European Continental Ancestry Group/statistics & numerical data
KW - Female
KW - Healthcare Disparities/ethnology
KW - Humans
KW - London/epidemiology
KW - Male
KW - Middle Aged
KW - Odds Ratio
KW - Physician's Practice Patterns
KW - Primary Health Care/statistics & numerical data
KW - Psychotic Disorders/complications/drug therapy/ethnology
KW - Young Adult
AU - R. Pinto
AU - M. Ashworth
AU - P. Seed
AU - G. Rowlands
AU - P. Schofield
AU - R. Jones
A1 - 
AB - BACKGROUND: Ethnicity is an important dimension in many aspects of psychosis. OBJECTIVE: To investigate ethnic differences in the primary care management of patients with psychosis. METHODS: Data were obtained from Lambeth DataNet, a database of computerized general practice case records derived from practices in an inner city London borough. We undertook a cross-sectional survey of patients with psychosis. Outcome measures: health screening, chronic disease management and prescribing data and differences between ethnic groups were expressed as odds ratios (ORs). RESULTS: One thousand six hundred and ninety-four of 165,911 (1.02%) registered patients had a diagnosis of psychosis; 1090 (64%) had ethnicity recorded; 501 were White and 403 were Black or Black British. There were no significant ethnic differences for blood pressure, cholesterol or HbA1c monitoring or control; cervical or mammography screening; treatment with hypotensives, statins, antidepressants, lithium, antipsychotics or atypical antipsychotics. Depot injectable antipsychotics were more likely to be prescribed to Black patients than other delivery modes: OR 2.10 (95% CI: 1.20-3.67). CONCLUSIONS: Measurable aspects of physical health care of patients with psychosis were similar, regardless of ethnicity. Increased use of the depot antipsychotic medication in black patients needs further exploration.
BT - Family practice
C5 - Healthcare Disparities
CP - 4
CY - England
DO - 10.1093/fampra/cmq014
IS - 4
JF - Family practice
N2 - BACKGROUND: Ethnicity is an important dimension in many aspects of psychosis. OBJECTIVE: To investigate ethnic differences in the primary care management of patients with psychosis. METHODS: Data were obtained from Lambeth DataNet, a database of computerized general practice case records derived from practices in an inner city London borough. We undertook a cross-sectional survey of patients with psychosis. Outcome measures: health screening, chronic disease management and prescribing data and differences between ethnic groups were expressed as odds ratios (ORs). RESULTS: One thousand six hundred and ninety-four of 165,911 (1.02%) registered patients had a diagnosis of psychosis; 1090 (64%) had ethnicity recorded; 501 were White and 403 were Black or Black British. There were no significant ethnic differences for blood pressure, cholesterol or HbA1c monitoring or control; cervical or mammography screening; treatment with hypotensives, statins, antidepressants, lithium, antipsychotics or atypical antipsychotics. Depot injectable antipsychotics were more likely to be prescribed to Black patients than other delivery modes: OR 2.10 (95% CI: 1.20-3.67). CONCLUSIONS: Measurable aspects of physical health care of patients with psychosis were similar, regardless of ethnicity. Increased use of the depot antipsychotic medication in black patients needs further exploration.
PP - England
PY - 2010
SN - 1460-2229; 0263-2136
SP - 439
EP - 446
EP - 
T1 - Differences in the primary care management of patients with psychosis from two ethnic groups: A population-based cross-sectional study
T2 - Family practice
TI - Differences in the primary care management of patients with psychosis from two ethnic groups: A population-based cross-sectional study
U1 - Healthcare Disparities
U2 - 20308245
U3 - 10.1093/fampra/cmq014
VL - 27
VO - 1460-2229; 0263-2136
Y1 - 2010
ER -